HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonino Neri Selected Research

Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)

1/2020A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia.
1/2018Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases.
6/2013Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome.
4/2013Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia.
12/2011Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocations.
1/2011Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia.
1/2011Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.
1/2009Identification of primary MAFB target genes in multiple myeloma.
1/2008Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemia.
2/2005Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonino Neri Research Topics

Disease

76Multiple Myeloma
10/2022 - 09/2002
76Neoplasms (Cancer)
02/2022 - 08/2002
36B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2022 - 01/2008
10Plasma Cell Leukemia
09/2021 - 02/2005
9Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 12/2011
8Disease Progression
12/2021 - 04/2006
8Paraproteinemias (Monoclonal Gammopathy)
01/2021 - 04/2005
7Carcinogenesis
01/2021 - 10/2002
4Genomic Instability
04/2021 - 07/2015
4Leukemia
10/2020 - 06/2014
4Thyroid Neoplasms (Thyroid Cancer)
01/2020 - 10/2015
4Trisomy (Trisomies)
01/2020 - 09/2003
4Lymphoma (Lymphomas)
04/2016 - 08/2003
4Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2016 - 10/2004
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2020 - 01/2016
3Monoclonal Gammopathy of Undetermined Significance
01/2019 - 09/2009
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2016 - 12/2006
3Chromosome Aberrations (Chromosome Abnormalities)
08/2014 - 09/2011
3Genetic Translocation (Chromosomal Translocation)
03/2007 - 08/2003
2Oncogene Addiction
01/2020 - 12/2017
2Breast Neoplasms (Breast Cancer)
01/2017 - 01/2017
2Bone Diseases (Bone Disease)
09/2015 - 11/2014
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2014 - 04/2012
2Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
11/2014 - 01/2013
2Chromosomal Instability (Chromosome Stability)
07/2014 - 08/2009
2Hypoxia (Hypoxemia)
05/2014 - 12/2007
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2013 - 10/2002
2Lymphocytosis
01/2013 - 01/2008
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2005 - 10/2004
2Squamous Cell Carcinoma of Head and Neck
01/2005 - 03/2004
1Cardiotoxicity
02/2022
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2021

Drug/Important Bio-Agent (IBA)

33Biological ProductsIBA
12/2021 - 04/2005
29MicroRNAs (MicroRNA)IBA
08/2021 - 08/2008
13Long Noncoding RNAIBA
11/2021 - 03/2016
13DNA (Deoxyribonucleic Acid)IBA
05/2020 - 03/2004
10Biomarkers (Surrogate Marker)IBA
12/2021 - 09/2002
10Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2020 - 02/2005
9Messenger RNA (mRNA)IBA
03/2021 - 10/2002
7Proteins (Proteins, Gene)FDA Link
10/2020 - 08/2002
7LigandsIBA
09/2020 - 04/2013
5Lenalidomide (CC 5013)FDA Link
10/2022 - 04/2013
5Pharmaceutical PreparationsIBA
02/2022 - 02/2010
5Rituximab (Mabthera)FDA Link
12/2021 - 10/2015
5Protein Isoforms (Isoforms)IBA
11/2021 - 07/2005
5Small Interfering RNA (siRNA)IBA
10/2019 - 12/2007
5Cyclin D1IBA
10/2015 - 09/2003
4Dexamethasone (Maxidex)FDA LinkGeneric
10/2022 - 04/2016
4ibrutinibIBA
12/2021 - 10/2020
4Interleukin-6 (Interleukin 6)IBA
10/2021 - 04/2013
4Untranslated RNA (Noncoding RNA)IBA
04/2021 - 06/2013
4Proteasome Endopeptidase Complex (Proteasome)IBA
10/2020 - 03/2008
4Bortezomib (Velcade)FDA Link
02/2019 - 03/2008
4mouse MIRN29 microRNAIBA
12/2017 - 10/2012
4Transcription Factors (Transcription Factor)IBA
08/2015 - 12/2011
4Cyclin D3IBA
01/2005 - 08/2003
3carfilzomibIBA
05/2022 - 01/2020
3CytokinesIBA
10/2021 - 01/2018
3Proteasome InhibitorsIBA
03/2021 - 03/2008
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2020 - 10/2015
3fludarabineIBA
11/2020 - 03/2012
3RNA (Ribonucleic Acid)IBA
10/2020 - 07/2015
3Phosphotransferases (Kinase)IBA
10/2020 - 11/2009
3Circulating Tumor DNAIBA
08/2020 - 01/2018
3Anaplastic Lymphoma KinaseIBA
01/2016 - 12/2006
3enzastaurinIBA
09/2011 - 07/2008
2elotuzumabIBA
10/2022 - 03/2022
2venetoclaxIBA
01/2022 - 09/2021
2Antisense OligonucleotidesIBA
11/2021 - 01/2021
2Bendamustine HydrochlorideFDA Link
01/2021 - 01/2018
2Immunoglobulins (Immunoglobulin)IBA
10/2020 - 04/2013
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018 - 01/2015
2Aromatase InhibitorsIBA
01/2017 - 01/2017
2Thalidomide (Thalomid)FDA Link
04/2016 - 08/2005
2Inosine Triphosphate (ITP)IBA
11/2014 - 04/2012
2Histone Deacetylase InhibitorsIBA
08/2012 - 02/2010
2Protein Kinase CIBA
03/2009 - 07/2008
2Protein Kinase C betaIBA
03/2009 - 07/2008
2AdiponectinIBA
01/2009 - 11/2008
2Cyclin DIBA
03/2007 - 10/2005
2AntigensIBA
04/2006 - 04/2005
1Interleukin-23 (Interleukin 23)IBA
10/2022
1B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
01/2022
13,4-dihydroxyphenylethanol (hydroxytyrosol)IBA
10/2021
1EstersIBA
10/2021
1Oleic Acid (Oleate)IBA
10/2021
1Interleukin-11 (Interleukin 11)IBA
10/2021
1idelalisibIBA
04/2021
1locked nucleic acidIBA
01/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021
12,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA
01/2021
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2021
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2021
1ofatumumabFDA Link
11/2020
1Tyrosine (L-Tyrosine)FDA Link
10/2020
1Tyrosine Kinase InhibitorsIBA
10/2020

Therapy/Procedure

22Therapeutics
01/2021 - 09/2003
5Drug Therapy (Chemotherapy)
01/2021 - 09/2003
2Salvage Therapy
05/2022 - 03/2022
2Immunotherapy
12/2021 - 04/2005